Reperfusion, specific thrombin inhibition and reocclusion after thrombolysis.
Chesebro
J H
JH
Fuster
V
V
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000991:Antithrombins / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D003327:Coronary Disease / Q000188:drug therapy*; D003328:Coronary Thrombosis / Q000188:drug therapy*; D004285:Dogs; D010875:Pipecolic Acids / Q000627:therapeutic use; D010980:Platelet Membrane Glycoproteins / Q000276:immunology; D012008:Recurrence; D013449:Sulfonamides; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000991:Antithrombins; D010875:Pipecolic Acids; D010980:Platelet Membrane Glycoproteins; D013449:Sulfonamides; D001120:Arginine; D010959:Tissue Plasminogen Activator; C031942:argatroban